Whitehawk Therapeutics (WHWK) Research & Development (2016 - 2026)
Whitehawk Therapeutics (WHWK) reported Research & Development of $17.2 million for Q1 2026, up 96.09% year-over-year from $8.8 million in Q1 2025, and down 9.41% on a QoQ basis from $19.0 million in Q4 2025.
Whitehawk Therapeutics (WHWK) has 11 years of Research & Development data on file, last reported at $17.2 million in Q1 2026.
- Quarterly Research & Development rose 96.09% year-over-year to $17.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99.4 million (up 115.05% YoY) and the FY2025 annual result came in at $91.0 million, up 78.25% from the prior year.
- Research & Development fell to $17.2 million in Q1 2026 per WHWK's latest filing, from $19.0 million in the prior quarter.
- Across five years, Research & Development topped out at $48.8 million in Q2 2025 and bottomed at $6.8 million in Q1 2022.
- The 5-year median for Research & Development is $12.8 million (2023), against an average of $14.2 million.
- Peak annual rise in Research & Development reached 272.79% in 2025, while the deepest fall reached 35.35% in 2025.
- Tracing WHWK's Research & Development over 5 years: stood at $9.4 million in 2022, then soared by 36.26% to $12.8 million in 2023, then climbed by 12.37% to $14.3 million in 2024, then jumped by 32.58% to $19.0 million in 2025, then dropped by 9.41% to $17.2 million in 2026.
- Per Business Quant, the three latest WHWK Research & Development figures stand at $17.2 million (Q1 2026), $19.0 million (Q4 2025), and $14.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | 17.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.23 Mn |
| Dec 31, 2025 | 19.02 Mn |
| Sep 30, 2025 | 14.35 Mn |
| Jun 30, 2025 | 48.81 Mn |
| Mar 31, 2025 | 8.79 Mn |
| Dec 31, 2024 | 14.35 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 13.09 Mn |
| Mar 31, 2024 | 13.59 Mn |
| Dec 31, 2023 | 12.77 Mn |
| Sep 30, 2023 | 11.89 Mn |
| Jun 30, 2023 | 13.32 Mn |
| Mar 31, 2023 | 10.96 Mn |
| Dec 31, 2022 | 9.37 Mn |
| Sep 30, 2022 | 8.77 Mn |
| Jun 30, 2022 | 7.73 Mn |
| Mar 31, 2022 | 6.79 Mn |
| Dec 31, 2021 | 7.23 Mn |
| Sep 30, 2021 | 5.75 Mn |
| Jun 30, 2021 | 3.05 Mn |
| Mar 31, 2021 | 3.64 Mn |
| Dec 31, 2020 | 5.32 Mn |
| Sep 30, 2020 | 2.40 Mn |
| Jun 30, 2020 | 3.55 Mn |
| Mar 31, 2020 | 1.83 Mn |
| Dec 31, 2019 | 2.13 Mn |
| Sep 30, 2019 | 2.84 Mn |
| Jun 30, 2019 | 2.26 Mn |
| Mar 31, 2019 | 5.59 Mn |
| Dec 31, 2018 | 5.25 Mn |
| Sep 30, 2018 | 4.35 Mn |
| Jun 30, 2018 | 4.23 Mn |
| Mar 31, 2018 | 4.03 Mn |
| Dec 31, 2017 | 3.78 Mn |
| Sep 30, 2017 | 2.94 Mn |
| Jun 30, 2017 | 3.17 Mn |
| Mar 31, 2017 | 2.26 Mn |
| Dec 31, 2016 | 1.99 Mn |
| Sep 30, 2016 | 3.48 Mn |
| Jun 30, 2016 | 2.90 Mn |
| Mar 31, 2016 | 2.99 Mn |